Loading
Latest filing published 18 Sept 2026 for CorMedix Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Janet Dillione appears in our data through filings on CorMedix Inc. shares, published by SEC (Form 4). The record holds 8 filings, for trades running from 17 January 2025 to 18 September 2026.
Sales make up the whole of the open-market record (2 sales, €353k). Besides market trades, the filings include 2 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
On 18 September 2026 came the latest disclosure, an option exercise in CorMedix Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations